Peter Høngaard Andersen and Jacob Hahn Michelsen proposed to join the board of Monsenso

Peter Høngaard Andersen and Jacob Hahn Michelsen proposed to join the board of Monsenso

Monsenso today announces that the board of Directors has decided to call for an Extraordinary General Meeting on January 29th, 2021, where two new members are proposed to be elected for the board.

Monsenso – a leading provider of mobile health solutions for mental health – plans to further strengthen the board by nominating two new professional board members with strong qualifications and competencies to support Monsenso in getting to the next level in the company’s growth journey: Peter Høngaard Andersen, formerly. Managing Director at Innovation Fund Denmark and VP at Lundbeck; Jacob Hahn Michelsen, SVP Private & Public at NNIT A/S.

Current board member Thomas Knudsen has offered to resign from his position on the board at the Extraordinary General Meeting. Thomas has supported Monsenso’s growth for several years from being a university research project spin-out to becoming an international publicly listed company on Nasdaq First North Growth Market Copenhagen. The board and the management of Monsenso would like to thank Thomas Knudsen for his outstanding work. His contributions have been essential in building up the product portfolio, securing the first rounds of financing, supporting the management and finally listing the company.

The new board is planning to constitute itself with Jukka Pertola as the Chairman and Jakob Bardram as the Vice Chairman until the next ordinary Annual General Meeting on April 14, 2021 where Jukka Pertola is expected to resign as the Chairman. Nomination of the new board members in January will help ensure an appropriate introduction, as well as a smooth transition and handover of responsibilities in the period leading up to the Annual General Meeting.

Jukka Pertola commented: ”Since I became a professional board member, I have been lucky to be invited to multiple boards of exciting companies, one of them being Monsenso. However, to address the good corporate governance requirements, I have decided to reduce my number of board positions and chairmanships. We have found an exceptionally strong pair of new board members, who can contribute to bringing Monsenso to the next level. Jacob Hahn Michelsen has extensive experience in pharma- and health-related software and IT, regulatory environment of medical applications and a valuable industry knowhow, while Peter Høngaard brings considerable experience from science and research, pharmaceuticals, neurology, intellectual property rights, innovation and funding.“

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso expands in the Middle East with new million deal with global pharmaceutical company

Monsenso expands in the Middle East with new million deal with global pharmaceutical company

Monsenso has entered a new million agreement with a global pharmaceutical company and hereby expands its activities to six countries in the Middle East. As part of the agreement, Monsenso will provide its solution for patient monitoring and treatment support in the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar and Bahrain.

Monsenso’s solution will be used to support the treatment of depression and schizophrenia. Patients are provided with an app, which is used to collect real-time patient-reported information and to give patients access to information about their disorder between consultations. Therapists gain access to a clinical web portal and can follow their patients remotely and gain valuable information about behavior, medication intake and symptoms and thus be able to provide a data-driven treatment and allow for proactive follow-up.
In addition, the solution supports communication between patients and therapists.

“We are very pleased with this agreement, which contributes to both expanding our geographic market coverage and our business with pharmaceutical companies in line with our growth strategy. ” says Thomas Lethenborg, CEO of Monsenso. “Depression and schizophrenia are among the most costly disorders for society and have major consequences for affected patients and relatives. Therefore, we are proud to be able to contribute to better treatment within these disease areas.”

The project will not affect Monsenso’s previously communicated plans and guidance for the 2020 financial year.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Sales and executive support internship

Sales and executive support internship

Innovative and ambitious company within personal health technology seeks a sales intern to support our company growth.

This is a full-time, unpaid internship in Copenhagen for a minimum five months (starting date can be discussed) and should be part of the applicant’s education

Key responsibilities 

  • Assist in lead management and sales processes
  • Participate ad prepare sales meetings
  • Assist sales force in Denmark and overseas
  • Present product demonstrations for high- and low-end customers
  • Create product and online/social media content  
  • Coordinate our participation at international conferences and exhibitions
  • Act as executive support to our management team
  • Update and maintain our CRM system

What we offer

We offer you a fantastic opportunity to join a young company, where you truly have the ability to make an impact and help shape the future in an exciting field. Personal health technology and mHealth are booming markets worldwide. You will have the opportunity to join us on our quest to provide innovative solutions for disease management and treatment support and thereby reduce the burden of mental illness in society. Our informal, fast-paced environment will give you great opportunities to grow professionally and personally.

Desired skills and expertise 

  • Taking a degree in Engineering, Business, Communications, psychology, public health or other relevant programme.
  • Skilled knowledge of MS Office (Excel, Word, PowerPoint) and preferably also of CRM systems.
  • Excellent English skills. Other major languages would be valued positively.
  • Good communication skills – orally as well as in writing.
  • Able to work independently with tasks – yet with good interpersonal skills.
  • Preferably knowledge about mHealth, health technologies and/or mental health

Please note, this is a full-time unpaid internship in Copenhagen, Vesterbro, for minimum five months (start date Jan or Feb 2021, but exact date can be discussed).

Contact 

For questions regarding this position contact Emil Deshasta at sales.support@monsenso.com 

This internship is only available for students enrolled at a Danish university.

To apply for this internship, please submit a Cover letter and your CV to jobs@monsenso.com